Advance biologics innovation with tools designed to accelerate discovery, development, and validation. Unlike traditional small molecules, biologics harness living systems to create highly targeted therapies - including monoclonal antibodies, CAR-T cells, gene therapies, and RNA-based drugs - offering precision treatment for complex diseases.
From cell-based assays and viral vector reagents to in vivo antibodies and RNA synthesis enzymes, our trusted suppliers provide the essential technologies that drive biologics research forward. Efficiently design, express, and test complex biologics with confidence - supported by leading innovators in cell therapy, gene delivery, antibody engineering, and RNA therapeutics.
Key suppliers that support biologics drug discovery:
BPS Bioscience – Experts in engineered cell lines and advanced assay systems for immunotherapy research
These solutions empower researchers to assess CAR-T cell potency, specificity, and off-target activity in a controlled, reproducible environment. BPS Bioscience offer:
- CAR-T target-expressing cell lines for cytotoxicity and activation studies
- Reporter cell lines featuring luciferase or GFP for high-throughput screening
- Checkpoint pathway models including PD-1/PD-L1 and CTLA-4
- Cell-based assays and expression kits for functional validation of immune responses
Contact our BPS specialists for more infomation.
Research Donors – Providers of fresh, high-quality human blood products for immunology research
Access to primary human materials ensures biologics are validated in physiologically relevant systems, bridging the gap between in vitro studies and clinical applications. Research Donors offer:
- Leukopaks optimised for large-scale T cell isolation
- Whole blood and PBMCs for immune profiling and assay development
Contact our blood specialists for more information.
Mirus Bio - Accelerating gene expression and vector production
These trusted reagents from Mirus streamline gene therapy workflows from early discovery to vector manufacturing. Mirus offer:
- TransIT® reagents for efficient delivery of DNA, RNA, and CRISPR components across diverse cell types
- VirusGEN® systems for scalable lentivirus and AAV vector production
Contact our drug discovery specialists for more information.
Lucigen - Specialists in competent cells for cloning and protein expression
Lucigen’s high-efficiency competent cells are essential tools in molecular biology workflows supporting biologics development. Lucigen offer:
- Chemically and electrocompetent cells for a variety of molecular biology applications
- Ideal for high-throughput cloning, plasmid propagation, and recombinant protein production
Contact our drug discovery specialists for more information.
Bio X Cell – Empowering in vivo monoclonal and fusion protein research
Bio X Cell provides in vivo-grade monoclonal antibodies and fusion proteins. These reagents are widely used in preclinical models to study immune mechanisms and validate novel therapeutic targets. Bio X Cell offer:
- Endotoxin- and azide-free formulations suitable for animal studies
- Validated antibodies for blocking, neutralisation, and depletion assays
- Fusion proteins for receptor–ligand interaction research
Contact our Bio X Cell specialists for more information.
Sino Biological – Offers an extensive portfolio of antibodies and recombinant proteins
Sino Biological’s reagents accelerate both discovery and safety evaluation stages of biologics research. Sino offer:
- Anti-payload antibodies supporting ADC (antibody-drug conjugate) development
- Target-specific antibodies for pharmacokinetic and immunogenicity analysis
Contact our Sino specialists for more information.
KACTUS – Driving RNA drug and exosome discovery
Kactus Bio supplies enzymes and reagents for RNA synthesis and genome engineering. These tools underpin development of RNA-based biologics, including mRNA vaccines and RNA interference therapies. KACTUS offer:
- In Vitro Transcription (IVT) reagents for efficient mRNA production
- MaxNuclease™ for complete degradation of DNA and RNA into short oligonucleotides
Contact our KACTUS specialists for more information.
System Biosciences (SBI) – Innovators in exosome isolation and analysis technologies
SBI provides exosome tools for the advancement of research into extracellular vesicle-based delivery platforms and biomarker discovery. SBI offer:
- ExoQuick for rapid exosome isolation from plasma, serum, and ascites samples
- ExoQuick-TC for isolation from cell culture media
- Assay kits for sensitive quantification and characterisation of exosomes
Contact our drug discovery specialists for more information.